Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome
The proinflammatory and proatherogenic mediator, soluble CD40 ligand (CD40L), is increased in the metabolic syndrome (MS) and released from platelets. We hypothesized that adiponectin modulates platelet function, and we sought to evaluate the association of adiponectin and sCD40L levels with platele...
| Main Authors: | , , , |
|---|---|
| Format: | info:eu-repo/semantics/article |
| Language: | eng |
| Published: |
Endocrinology and Metabolism
2012
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/22908 |